Skip to main content
VCOM Campus

Louisiana

louisiana

Louisiana Research Day 2024

Louisiana Research Day 2024

Tags: Research

Location: VCOM-Louisiana, 4408 Bon Aire Dr, Monroe, LA 71203

The Edward Via College of Osteopathic Medicine (VCOM) – Louisiana Campus will hold its 2nd Annual Via Research Recognition Day on Friday, February 23, 2024. Research Day is a significant event for VCOM and supports the mission of the College to provide medical education and research that prepares globally-minded, community-focused physicians and improves the health of those most in need.

Registration

Registration is FREE and is required for all participants, including students and poster presenters. Registration opens on October 4, 2023, and the deadline to register is Monday, January 8, 2024. 

REGISTER NOW

With registration for this event, you get:

  • Program materials
  • Breakfast and lunch will be provided during the event
  • Full access to all event activities

For any problems with registration, please email researchday-lc@ulm.vcom.edu

Agenda

Research Day Agenda (PDF)

Program

Research Day Program Book

Speakers

  • Dr. Jonathan Auguste, PhD

    Associate Professor for Arbovirology at Virginia Tech

  • Dr. Albert Kozar, DO, FAOASM, R-MSK  

    Associate Professor for OMM and Sports Medicine at VCOM Virginia

    Director of the Osteopathic Neuromusculoskeletal Medicine (ONMM) Residency

How do I participate?

Attendees are invited to share their research in poster format. Poster abstracts must be accepted for the event for posters to be displayed. The Via Research Recognition Day features an optional poster competition with distinct categories; Research by a medical resident can be in the following categories: Biomedical Research, Clinical Research, Clinical Case Reports, Educational Research and Simulation Research.

Guidelines for Writing Research Abstracts for Posters (DOC)

Abstract Submission Form



Abstracts must be submitted electronically using the Abstract Submission Form at the link above. The deadline for abstract submission is Monday, January 8, 2024.

Please note: In the interest of professionalism and fairness, no extensions for abstract submission will be granted.

For questions about abstract submissions or participation in the poster competition, please email the Research Day Committee at researchday-lc@ulm.vcom.edu.

When an abstract is accepted, the submitting author will receive further instructions on poster submission via email.

VCOM provides free poster printing for any meeting attendee with an accepted abstract. Details will be sent to submitting authors with the abstract acceptance email.

Poster Template (PPT) (Please save poster file name as: lastname,firstname-VCOM-RD24)

Poster Submissions are due by Friday, February 9th, 2024

What will this conference offer?

The Via Research Recognition Day is a forum for health professionals and scientists at academic institutions, teaching hospitals and practice sites to present or benefit from new research innovations and programs intended to improve the health of all humans. By attending the oral presentations and poster sessions, participants will have the opportunity to learn cutting edge information in the physiological bases of osteopathic manipulative therapy efficacy, new trends in physician-based research networks, and how to develop innovative research projects with high impact for human health. By attending the poster session, participants will also learn about the biomedical, clinical and educational research activities at VCOM and its partner institutions and will have an opportunity to identify new collaborative research opportunities.

Who should attend?

Medical and pharmacology students, physicians, physician assistants, biomedical researchers, nurse practitioners, public health professionals, medical residents, and other health profession students and others interested in primary care issues and research.

Disclosure Statement

It is the policy of the VCOM Medical Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All participating faculty are expected to disclose to the participants any real or apparent conflict of interest related to the content of their presentations.

Campus: Louisiana
When: February 23, 2024 8:00am to 5:00pm CST

Deja′ Trammell

Deja Trammell
Deja′ Trammell, PhD
Director for OMS 3 and OMS 4 Academic Counseling
Office: 345
Department/Discipline: Center for Institutional, Faculty and Student Success
Campuses: Auburn, Carolinas, Virginia, Louisiana
0

Haley Wheeler

Haley Wheeler
Haley Wheeler
Coordinator for Student Affairs
Department/Discipline: Student Services
Campus: Louisiana
0

Jasmine Belton

Jasmine Belton
Jasmine Belton, MLS (ASCP)
Anatomy Lab Supervisor
Office: 224
Department/Discipline: Anatomical Sciences
Campus: Louisiana
0

Hassan Y. Ebrahim

Ebrahim Hassan
Hassan Ebrahim, BPharmSci, MPharmSci, PhD
Assistant Professor for Pharmacology

Dr. Ebrahim earned his bachelor's degree in Pharmaceutical Sciences from the College of Pharmacy at Helwan University, Egypt, where he also completed his master's degree in the same field. He then got his Doctor of Philosophy in Pharmacy from the University of Louisiana Monroe, United States. His PhD research work focused on developing bioactive molecules derived from natural sources, including plants, fungi, mushrooms, lichens, and marine organisms, to inhibit breast cancer progression in preclinical models.

Dr. Ebrahim began his academic career as an Assistant Professor at the College of Pharmacy, Helwan University, where he later advanced to the rank of Associate Professor. He also worked as a postdoctoral research fellow in Dr. El Sayed’s lab at the University of Louisiana Monroe, focusing on anti-prostate cancer drug discovery from natural products. Currently, Dr. Ebrahim serves as an Assistant Professor in the Department of Biomedical Sciences at Edward Via College of Osteopathic Medicine (VCOM), University of Louisiana Monroe.
 

Education

Year University Degree
2012-2016 The University of Louisiana Monroe, College of Pharmacy, Monroe, Louisiana, USA Doctor of Philosophy in Pharmacy (PhD Pharm)
2005-2008 Helwan University, College of Pharmacy, Cairo, Egypt Master of Pharmaceutical Sciences (MPharmSci).
1999-2004 Helwan University, College of Pharmacy, Cairo, Egypt Bachelor of Pharmaceutical Sciences (BPharmSci), Excellent with Honors of Merits

 

Research Interests

Nature has long been, and will undoubtedly remain, a crucial source of innovation in drug discovery. Natural products and their derivatives constitute a significant portion of FDA-approved drugs, particularly in oncology and infectious disease treatment. My research group leverages extensive expertise in molecular pharmacology and medicinal chemistry to develop anticancer lead compounds and potential drug candidates. We isolate and characterize bioactive metabolites from various natural sources, including lichens, plants, fungi, and marine organisms. Currently, my research focuses on developing natural product-based lead compounds for targeting solid tumors. Among the promising proto-oncogene targets in cancer therapy, receptor tyrosine kinases (RTKs) have emerged as a key focus, with c-Met being a particularly viable candidate for investigation. c-Met, also known as the hepatocyte growth factor (HGF) receptor, plays a pivotal role in the initiation and progression of multiple cancers, including breast and prostate. c-Met/HGF signaling pathway regulates key cellular processes such as proliferation, migration, invasion, survival, and angiogenesis, all of which contribute to cancer development and metastasis. Given its involvement in tumorigenesis and drug resistance, my research group is focusing on discovering natural product-based c-Met modulators for the control of Met-addicted malignancies.


 

Selected publications

  • Tarun, M.T.I.; Elsayed, H.E.; Ebrahim, H. Y.; El Sayed, K.A. The Olive Oil Phenolic S-(-)-Oleocanthal Suppresses Colorectal Cancer Progression and Recurrence by Modulating SMYD2-EZH2 and c-MET Activation. Nutrients, 2025, 17, 397.
  • Ethar A. Mudhish, Ebrahim, H.Y., Iman E. Helal, Abdullah T. Alhowiriny, and Khalid A. El Sayed. Cannabidiol Suppresses Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence through Modulating Tryptophan Catabolism. ACS Pharmacology & Translational Science 2024, 7(12), 3902-3913.
  • Sweilem B. Al Rihani, Khaled H. Elfakhri, Ebrahim, H. Y., Nour F. Al-Ghraiybah, Amer E. Alkhalifa, Khalid A.El Sayed, and Amal Kaddoumi. The Usnic Acid Analogue 4-FPBUA Enhances the Blood–Brain Barrier Function and Induces Autophagy in Alzheimer’s Disease Mouse Models. ACS Chemical Neuroscience 2024 15(17), 
    3152-3167.
  • Oliver C. McGehee, Ebrahim, H. Y., Ashkan H. Rad, Khaldoun S. Abdelwahed, Ethar A. Mudhish, Judy A. King, Iman E. Helal, Sharon A. Meyer; Khalid A. El Sayed. Towards Developing Novel Prostate Cancer Recurrence Suppressors: Acute Toxicity of Pseurotin A, an Orally Active PCSK9 Axis-Targeting Small-Molecule in Swiss Albino Mice. Molecules 2023, 28, 1460.
  • Abdelwahed, Khaldoun S., Abu Bakar Siddique, Ebrahim, H. Y., Mohammed H. Qusa, Ethar A. Mudhish, Ashkan H. Rad, Mourad Zerfaoui, Zakaria Y. Abd Elmageed, and Khalid A. El Sayed. Pseurotin A Validation as a Metastatic Castration-Resistant Prostate Cancer Recurrence-Suppressing Lead via PCSK9-LDLR Axis Modulation. Marine Drugs 2023, 21, 4, 215.
  • Ebrahim, H. Y., Mohamed S Mady, Hanaa B Atya, Sahar A Ali, Heba E Elsayed, Fatma A Moharram. Melaleuca rugulosa (Link) Craven Tannins: Appraisal of anti-inflammatory, radical scavenging activities, and molecular modeling studies. J Ethnopharmacol, 2022, 298, 115596.
  • El Sayed, KA; Siddique, AB, Ebrahim, H.Y. Oleocanthal Isolation and Cancer Treatment. US Patent number 10945983, 2021.
  • Halawa, A. H.; Elgammal, W. E.; Hassan, S. M.; Hassan, A. H.; Nassar, H. S.; Ebrahim, H. Y.; Mehany, El-Agrody, A. M. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons. Bioorganic Chem. 2020, 98, 103725.
    Elsayed, H. E; Ebrahim, H. Y., Haggag, E. G.; Kamal, A. M.; El Sayed, K. A. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies. Bioorg. Med. Chem. 2017, 25 (24), 6297-6312.
  • Ebrahim, H.Y.; Mohyeldin, M. M.; Hailat, M. M.; El Sayed, K. A. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies. Bioorg. Med. Chem. 2016, doi:10.1016/ j.bmc.2016.09.032
  • Ebrahim, H.Y.; El Sayed, K. A. Discovery of novel antiangiogenic marine natural product scaffolds. Mar. Drugs 2016, 14, 57.
  • Ebrahim, H.Y.; Elsayed, H. E.; Mohyeldin, M. M.; Akl, M. R.; Bhattacharjee, J.; Egbert, S.; El Sayed, K. A. Norstictic acid inhibits breast cancer cell proliferation, migration, invasion, and in vivo invasive growth through targeting c-Met. Phytother. Res. 2016, 60, 557-566
Download CV
Office: Suite 330, Office 346
Department/Discipline: Pharmacology
Campus: Louisiana

Awards

  • Edward Via College of Osteopathic Medicine, Louisiana Campus, Biomedical Faculty Award of the Musculoskeletal System Block Award, December 2024
  • Edward Via College of Osteopathic Medicine Research Recognition Day, Poster Presentation Award, April 2024
  • Edward Via College of Osteopathic Medicine, Louisiana Campus, Biomedical Faculty Award of the Integumentary, Hematological, and Lymphatic System Block Award, March 2024
  • Edward Via College of Osteopathic Medicine, Louisiana Campus, Biomedical Faculty Award of the Musculoskeletal System Block Award, December 2023
  • The University of Louisiana Monroe, Outstanding Graduate Student Award, December 2016
  • International Pharma Conference, Podium Presentation Award, September 2017
  • The University of Louisiana at Monroe, Podium Presentation Award, Graduate Research Symposium, April 2016
  • The University of Louisiana Monroe, Poster Presentation Award, Graduate Research Symposium, April 2015

Activities

  • Member, American Association of Pharmaceutical Scientists (AAPS)
  • Member, Egyptian Pharmacists Syndicate (EPS)
  • Managing Editor, Journal of Advanced Pharmacy Research (JAPR)
  • Editor, Cureus Journal of Medical Sciences, Springer Nature, Edward Via College of Osteopathic Medicine Channel
  • Guest Editor, MDPI Biomedicines
  • Guest Editor, MDPI Nutrients
  • Review Editor, Frontiers in Chemistry
  • Handling Editor, Frontiers in Public Health
  • Editor, Journal of Breast Cancer Survival
Fax: 318-372-7280
0
Subscribe to Louisiana